Johnson Chemical Pharmaceutical Works Co., Ltd. (TPEX:4747)
Taiwan · Delayed Price · Currency is TWD 25.25
+0.50 (2.02%)
Sep 8, 2026, 1:30 PM CST
TPEX:4747 Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,296 | 2,660 | 3,213 | 3,655 | 1,537 | 1,052 | |
Market Cap Growth | -19.79% | -17.20% | -12.10% | 137.81% | 46.08% | -5.78% |
Enterprise Value | 2,679 | 1,775 | 2,309 | 2,814 | 1,448 | 940 |
Last Close Price | 25.25 | 28.98 | 34.04 | 39.03 | 21.14 | 13.84 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 25.94 | 49.72 | 38.19 | 45.86 | 23.70 | 21.43 |
Forward PE | - | 14.55 | 14.55 | 14.55 | 14.55 | 14.55 |
PS Ratio | 3.97 | 4.67 | 5.25 | 6.02 | 3.11 | 2.56 |
PB Ratio | 1.32 | 1.56 | 1.89 | 2.19 | 1.76 | 1.24 |
P/TBV Ratio | 1.32 | 1.56 | 1.89 | 2.19 | 1.77 | 1.25 |
P/FCF Ratio | - | 347.26 | 64.66 | 35.20 | 51.27 | 69.87 |
P/OCF Ratio | 94.52 | 37.10 | 51.09 | 26.69 | 17.14 | 20.10 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 4.64 | 3.12 | 3.78 | 4.64 | 2.93 | 2.28 |
EV/EBITDA Ratio | 34.22 | 18.95 | 19.37 | 23.47 | 14.47 | 12.11 |
EV/EBIT Ratio | 46.27 | 24.21 | 23.51 | 28.48 | 17.70 | 15.09 |
EV/FCF Ratio | - | 231.76 | 46.47 | 27.11 | 48.30 | 62.40 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.37 | 0.15 | 0.09 | 0.10 | 0.07 | 0.09 |
Debt / EBITDA Ratio | 8.13 | 2.79 | 1.26 | 1.34 | 0.60 | 1.03 |
Debt / FCF Ratio | - | 34.07 | 3.02 | 1.55 | 2.00 | 5.31 |
Net Debt / Equity Ratio | 0.22 | -0.52 | -0.54 | -0.55 | -0.12 | -0.14 |
Net Debt / EBITDA Ratio | 4.83 | -9.51 | -7.72 | -7.73 | -1.08 | -1.58 |
Net Debt / FCF Ratio | -9.38 | -116.30 | -18.51 | -8.93 | -3.62 | -8.12 |
Asset Turnover | 0.25 | 0.28 | 0.31 | 0.40 | 0.48 | 0.39 |
Inventory Turnover | 1.94 | 2.07 | 2.60 | 2.72 | 2.12 | 1.57 |
Quick Ratio | 0.47 | 3.30 | 6.96 | 5.52 | 1.70 | 1.65 |
Current Ratio | 0.74 | 3.79 | 7.81 | 6.18 | 2.47 | 2.50 |
Return on Equity (ROE) | 5.25% | 3.14% | 4.98% | 6.27% | 7.54% | 5.75% |
Return on Assets (ROA) | 1.62% | 2.26% | 3.10% | 4.07% | 4.95% | 3.66% |
Return on Invested Capital (ROIC) | 2.78% | 7.73% | 9.94% | 10.35% | 8.74% | 6.96% |
Return on Capital Employed (ROCE) | 3.40% | 4.30% | 5.50% | 5.60% | 9.40% | 7.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 3.89% | 2.01% | 2.62% | 2.18% | 4.22% | 4.67% |
FCF Yield | -1.78% | 0.29% | 1.55% | 2.84% | 1.95% | 1.43% |
Dividend Yield | 2.04% | 1.81% | 2.57% | 1.92% | 4.73% | 5.24% |
Payout Ratio | 87.98% | 146.96% | 80.03% | 75.33% | 67.12% | 117.39% |
Buyback Yield / Dilution | 0.03% | -0.04% | -22.56% | -26.25% | 0.07% | 0.04% |
Total Shareholder Return | 2.07% | 1.77% | -19.99% | -24.33% | 4.80% | 5.28% |